Colorectal Cancer Care in China: Questions About Long-Term Follow-Up

What long-term follow-up after colorectal cancer actually involves

Follow-up after colorectal cancer is not one appointment. It is a scheduled programme of clinical visits, blood tests, imaging and colonoscopy that continues for years after initial treatment. The exact tests, intervals and duration depend on the stage at diagnosis, the pathology findings, the type of surgery or systemic therapy you received and your individual risk of recurrence or a new primary cancer.

This is why a generic follow-up schedule copied from another patient is not useful. Two people who both had colon cancer may need different surveillance if their stage, nodal status, resection margins, mismatch repair status or adjuvant treatment differed. The treating team uses your own pathology and staging records to decide what to check and when.

For an overseas patient, the practical question is narrower: can a hospital in China take over or supplement this surveillance in a way that is safe, documented and connected to your care at home? That requires records, a named clinical contact and a clear plan for sharing results.

The records that make follow-up possible

A follow-up visit without the original treatment records is limited. The receiving clinician needs to know what was found, what was done and what has already been checked. Without that context, it is difficult to judge whether a new symptom or scan finding is expected, new or unrelated.

The most useful documents are the ones that describe the cancer itself and the treatment already delivered. These are not the same as a discharge summary, which often omits pathology detail.

Ask your treating hospital for copies of the following, in English or with a certified translation:

If any of these are missing, tell the receiving team what you do not have rather than waiting until every document is collected. A clinician can often start a conversation with a partial file and request specific missing items. Do not delay assessment of new or worsening symptoms while records are being gathered.

• The original pathology report, including tumour type, grade, margins, lymph node count and any molecular or mismatch repair results
• The staging documentation used at diagnosis, including imaging reports and the stage recorded by the treating team
• Operative notes for any colorectal surgery, including the type of resection and whether a stoma was formed
• Chemotherapy, radiotherapy or immunotherapy summaries, including agents, dates and any dose reductions or stopped cycles
• The most recent surveillance results: blood tests, imaging and colonoscopy reports with dates
• A current medication list and any known allergies or reactions

Why staging and pathology records matter for follow-up decisions

Cancer stage describes the extent of disease at diagnosis. Staging approaches differ between cancer types, and the stage helps inform treatment and surveillance discussions. It is not the same as grade, which describes how abnormal the cancer cells look under a microscope. A follow-up plan built on an incorrect or incomplete stage can lead to unnecessary tests or missed checks.

If your original staging was done elsewhere, the receiving team may want to review the imaging and pathology rather than accept a summary. This is a records-based review, not a new diagnosis. It can clarify what was known at diagnosis and whether the follow-up plan should be adjusted.

A staging or pathology review does not by itself establish eligibility for any treatment in China, and it does not replace your home team's ongoing role. It is one input into a follow-up discussion.

Related treatment reference

Questions to ask the receiving team before you travel

The answers to these questions determine whether a follow-up visit in China is practical for your situation, and they are worth asking in writing so you have a record of what was agreed. You are not asking the team to guarantee an outcome. You are asking what they can and cannot do with the records you have, and how the visit would fit into your existing care. If the answers are vague, ask for clarification before booking travel. A follow-up visit that produces results no one at home can act on has limited value.

Start with the surveillance question, because it is the one that decides everything else. Ask the receiving team what checks they would recommend for your stage and treatment history, and how that compares with the schedule your home team has already set. If the two plans differ, ask which differences matter and which are simply local habit. A team that cannot answer this without your pathology and staging records is telling you something useful: send those first, then ask again.

Ask separately about the mechanics of the visit. Will a colonoscopy or imaging be part of the same trip, or arranged on a later date? Who explains the results, and in what language? How long after the visit will a written report be ready, and in what format? These are administrative questions, and the specific hospital is the only reliable source for them. Do not accept a general answer about how things work in China; ask what this provider does for this visit.

Then ask about the handover. Name the clinician at home who should receive the results, and ask how the receiving team will send them and how long that takes. If your home team has a specific question, put it in writing before the visit so the answer addresses it directly. A focused question, such as whether a particular finding needs earlier review, is easier to answer than a general request for an opinion.

Finally, ask what happens if something unexpected is found. A follow-up programme is designed to detect changes, so the possibility is part of the plan rather than a failure of it. Ask how the team would discuss a new finding with you and with your home clinicians, and who would coordinate the next step. You do not need a detailed contingency plan in advance, but you do need to know that a route exists.

Keep the enquiry narrow. Describe your diagnosis, the treatment you have had, the follow-up currently planned and the one question you most want answered. That is enough for the team to say whether a China-based visit is worth arranging, and it avoids sending a complete archive before anyone has agreed to review it.

• Given my stage and treatment history, what surveillance would you recommend, and how does it compare with what my home team has planned?
• Which records do you need before the visit, and which can be reviewed afterwards?
• Will the visit include a colonoscopy or imaging, or will those be arranged separately?
• Who will explain the results to me, and in what language?
• How will the results be shared with my home clinicians, and in what format?
• If something unexpected is found, what is the process for discussing it with my home team?

Continuity between China and your home clinicians

A frequent practical problem in overseas follow-up is not a missed test. It is a result that never reaches the clinician who needs it. A scan report in one system and a blood test in another may never be reviewed together, and neither clinician sees the full picture.

Before any follow-up visit in China, decide who at home will receive the results and how. That may be your oncologist, surgeon, primary care clinician or a specialist nurse. Ask the receiving team what format they can provide and how long that takes. Do not assume a report will be sent automatically.

If your home team has a specific question, put it in writing before the visit. A focused question, such as whether a particular finding needs earlier review, is easier to answer than a general request for an opinion.

Keep your own copy of every report. If you change clinicians or move again, your records travel with you.

Practical preparation and a realistic next step

Follow-up in China can be arranged through public tertiary hospitals or private international hospitals. The right route depends on what you need: a records review, a surveillance colonoscopy, imaging or a multidisciplinary discussion. Availability, scheduling and language support vary by hospital and must be confirmed with the specific provider.

Start with a short summary rather than a complete archive. Describe your diagnosis, the treatment you have had, what follow-up is currently planned and the specific question you want answered. That is enough for an initial review of whether a China-based follow-up visit is worth arranging.

An initial enquiry is free and does not commit you to a proxy consultation or any treatment. If a records-based opinion is useful, that can be discussed separately. The hospital, not a coordination service, decides whether it can accept your case and what surveillance it recommends.

If you have new or worsening symptoms, seek local medical assessment first. Do not delay urgent care for an overseas enquiry.